AKT1 and acute myeloid leukemia: Thus, the present study has revealed a critical role Pim kinases play in enhancement of the mTORC1 pathway downstream of the FLT3-ITD and suggests that these kinases are promising targets for the combined therapy with the PI3K/Akt pathway inhibitors against FLT3-ITD-positive AML associated with poor prognosis.